Most medicines are made in fixed strengths, in fixed formats, in runs of millions.
Patients aren't.
We are making personalized medicine with
Our pharmaceutical 3D printing platform for personalized peptide medicines
One dose does not fit everyone
Peptide therapeutics are advancing quickly, but fixed-dose manufacturing often forces prescribers to choose the closest available strength, while traditional compounding can be difficult to scale and standardize.
PERSONALIZ3D™ brings pharmaceutical 3D printing to the point of care to make personalized dosing more precise, repeatable, and documentable.
PERSONALIZ3D™ brings pharmaceutical 3D printing to the point of care to make personalized dosing more precise, repeatable, and documentable.
PERSONALIZ3D™ is a platform
PERSONALIZ3D™ brings together the formulation science, the production hardware, and the data that connects them.
|
System GMP-ready pharmaceutical 3D printing systems are placed where prescribing happens, so a personalized dose is produced on-site. |
Product Peptide formulations developed for printed dosage forms — stability, release behaviour, and palatability are proprietary. |
Data Every dose is a digital record. Output data accumulate into something a manual compounding process can't easily produce: a reproducible, auditable trail. |
Pharmaceutical 3D printing system
|
CraftMake™ is a GMP-ready pharmaceutical 3D printing system developed by Craft Health. In July 2026, PharmaTher announced a collaboration with Craft Health to evaluate CraftMake™ for the production of personalized peptide dosage forms under the PERSONALIZ3D™ platform.
|
What we can print
Adherence usually fails for practical reasons, not clinical ones. PERSONALIZ3D™ is designed to deliver the same personalized formulation in the format a given patient will actually take.
Peptides are growing quickly
$140.9B → $294.6B
Global peptide therapeutics market, 2025 to 2033 (CAGR of 8.7%).
Personalized medicine is growing quickly
$567.1B → $1,196.2B
Global personalized medicine market, 2024 to 2033 — (CAGR of 8.8%).
PERSONALIZ3D™ is built at the point where the two meet.
Business model
|
Proprietary products Own personalized peptide products, commercialized directly or through partners. |
Placements & services Placing systems in pharmacies, supported by consumables and ongoing recurring services. |
CDMO services Development & production services for customized formulations, built, validated, and produced. |
Center of Excellence
|
Under our collaboration, PD Labs will provide the real-world pharmacy environment and compounding expertise to develop and integrate pharmaceutical 3D printing into pharmacy operations while serving as the initial commercial hub and development site for a scalable, repeatable pharmacy deployment model for proprietary products and system placements and support.
|
Who we work with
|
503A compounding pharmacies |
Telehealth and Wellness brands |
Pharmaceutical and Biotech |
Government and Hospitals |
Multi-Peptide Gummy
|
Our proprietary format: multiple peptides and dietary supplements delivered in a single personalized gummy, produced to a patient's prescribed combination rather than assembled from separate products.
One format, one daily dose, built around the patient rather than the production line. |
Courtesy of Craft Health Ltd.
|
Other peptides: BPC-157 · KPV · TB-500 · MOTS-c · Epitalon · Semax
Sign Up for Press Releases
Follow Us
OTCQB: PHRRF | CSE:PHRM
© COPYRIGHT 2026. PharmaTher Holdings Ltd. ALL RIGHTS RESERVED.
"The product candidates described on this website are investigational and have not been approved by the U.S. Food and Drug Administration (FDA) or any other regulatory authority. Safety and efficacy have not been established."